Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.6 CHF | +6.91% | +7.41% | +9.43% |
May. 17 | R&S Group Raises FY24 Revenue Outlook | MT |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 222M 244M | Sales 2025 * | 243M 267M | Capitalization | 324M 356M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 28 30.8 | EV / Sales 2024 * | 1.37 x |
Net cash position 2024 * | 19.67M 21.64M | Net cash position 2025 * | 28.1M 30.92M | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
12.3
x | P/E ratio 2025 * |
12.1
x | Employees | 616 |
Yield 2024 * |
3.02% | Yield 2025 * |
3.15% | Free-Float | 50.69% |
1 day | +6.91% | ||
1 week | +7.41% | ||
Current month | +9.95% | ||
1 month | +8.92% | ||
3 months | +7.41% | ||
6 months | +16.58% | ||
Current year | +9.43% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 11.6 | +6.91% | 460,480 |
24-05-16 | 10.85 | -0.91% | 38,625 |
24-05-15 | 10.95 | -3.52% | 28,170 |
24-05-14 | 11.35 | +5.09% | 57,837 |
24-05-13 | 10.8 | 0.00% | 21,730 |
Delayed Quote Swiss Exchange, May 17, 2024 at 11:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.43% | 357M | |
+7.48% | 46.24B | |
+168.33% | 5.05B | |
-1.53% | 2.84B | |
-2.92% | 2.8B | |
+102.30% | 1.29B | |
-31.20% | 1.1B | |
-8.88% | 1B | |
+50.05% | 971M | |
-15.43% | 909M |
- Stock Market
- Equities
- RSGN Stock